Nuffield Division of Clinical Laboratory Sciences
Head of Division
About NDCLS
Our aim is to study the pathology of human disease from the molecular to systems level, and to translate our findings into treatments for human disorders.
Read moreLatest publications
-
AML-348 A Phase Ib/II Study of Ivosidenib With Venetoclax +/- Azacitidine in IDH1-Mutated Hematologic Malignancies
Journal article
Lachowiez C. et al, (2022), Clinical Lymphoma, Myeloma and Leukemia, 22, S240 - S241
-
AML-399 A Phase 2, Open-Label, Multiarm, Multicenter Study to Evaluate Magrolimab Combined With Antileukemia Therapies for First-Line, Relapsed/Refractory, or Maintenance Treatment of Acute Myeloid Leukemia (AML)
Journal article
Vyas P. et al, (2022), Clinical Lymphoma, Myeloma and Leukemia, 22
-
Impact of enteral immunonutrition on infectious complications and immune and inflammatory markers in cancer patients undergoing chemotherapy: A systematic review of randomised controlled trials
Journal article
Miller LJ. et al, (2022), Clinical Nutrition, 41, 2135 - 2146
-
A cluster of type II interferon-regulated genes associates with disease activity in patients with systemic lupus erythematosus
Journal article
Siddiqi KZ. et al, (2022), Journal of Autoimmunity, 132
The Latest News
The Gene Therapists Headline at Glastonbury 2022
26 September 2022
Rosie Munday writes about her experience taking science to the masses at the Glastonbury Festival.
Six RDM research groups secure LEAF Sustainability Awards
22 July 2022
The Laboratory Efficiency Assessment Framework (LEAF) aims to support research groups to embed sustainability into their work.
James Davies named as Lister Research Prize Fellow
23 June 2022
James Davies has been named as one of eight researchers selected for the 2022 Fellowship scheme.